Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 274618Generated: October 31, 2026

(2-Butyl-4-chloro-1-((2'-(1-trityl-1H-tetraazol-5-YL)(1,1'-biphenyl)-4-YL)methyl)-1H-imidazol-5-YL)methanol → N-Trityl Losartan Carboxaldehyde

https://huagongshe.com/reaction/274618

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(2-Butyl-4-chloro-1-((2'-(1-trityl-1H-tetraazol-5-YL)(1,1'-biphenyl)-4-YL)methyl)-1H-imidazol-5-YL)methanolHCID 11643218—
Reactant2-butyl-1-[(2'-t-butoxycarbonylbiphen-4-yl)methyl]-5-chloro-1H-imidazole-4-methanolHCID 131717644—
ProductN-Trityl Losartan CarboxaldehydeHCID 11657587—

Reaction Steps

This Step A compound can be prepared as described in Example 3, Step A except that 2-butyl-1-[(2'-{N-triphenylmethyltetrazol-5-yl}{1,1'-biphenyl}-4-yl)methyl]-4-chloro-1H-imidazole-5-methanol can be used as the starting material for the oxidation instead of 2-butyl-1-[(2'-t-butoxycarbonylbiphen-4-yl)methyl]-5-chloro-1H-imidazole-4-methanol.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05389660
Source datasetuspto-grants-1995_02
ORD IDord-50d9bdc07a164f708c0a370f4e76035c
Source noteuspto-grants-1995_02